Alpha 2.0
Login Register
» Authors » R H Aster

R H Aster

Explore the profile of R H Aster including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 203
Citations 2088
Followers 0
Related Specialties
Hematology
General Medicine
Pathology
Top 10 Co-Authors
T J Kunicki
J E Menitove
J G McFarland
B R Curtis
G P Visentin
P J Newman
R J Duquesnoy
J L Gottschall
G A Becker
D J Christie
Published In
Transfusion
Blood
Am J Hematol
J Clin Invest
N Engl J Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia
Park B, Kumar M, Nagalla S, De Simone N, Aster R, Padmanabhan A, et al.
Transfus Apher Sci . 2018 Sep; 57(4):561-565. PMID: 30244713
Heparin induced thrombocytopenia (HIT) is a serious adverse drug reaction caused by transient antibodies against platelet factor 4 (PF4)/heparin complexes, resulting in platelet activation and potentially fatal arterial and/or venous...
2.
Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis
Warkentin T, Greinacher A, Gruel Y, Aster R, Chong B
J Thromb Haemost . 2012 Sep; 9(12):2498-500. PMID: 22947414
No abstract available.
3.
Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management
Aster R, Curtis B, McFarland J, Bougie D
J Thromb Haemost . 2009 Apr; 7(6):911-8. PMID: 19344362
Drug-induced immune thrombocytopenia (DITP) can be triggered by a wide range of medications. Although many cases of DITP are mild, some are characterized by life-threatening bleeding symptoms. The pathogenesis of...
4.
HPA-1a/b(PlA1/A2,Zwa/b): the odyssey of an alloantigen system
Aster R, Newman P
Immunohematology . 2007 Apr; 23(1):2-8. PMID: 17425409
No abstract available.
5.
Heparin-induced immune thrombocytopenia - a clinical or laboratory diagnosis?
Aster R
J Thromb Haemost . 2006 Apr; 4(4):757-8. PMID: 16634743
No abstract available.
6.
Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors
Aster R, Curtis B, Bougie D, Dunkley S, Greinacher A, Warkentin T, et al.
J Thromb Haemost . 2006 Feb; 4(3):678-9. PMID: 16460451
No abstract available.
7.
Heparin-induced thrombocytopenia and thrombosis
Davoren A, Aster R
Am J Hematol . 2005 Dec; 81(1):36-44. PMID: 16369980
Heparin, employed clinically for more than 50 years, is still a widely used anticoagulant. Unfortunately, some patients given this agent develop thrombocytopenia and thrombosis. Because this side effect can have...
8.
Heparin-independent activation of platelets by HIT antibodies: a clue to the etiology of delayed thrombocytopenia/thrombosis in patients given heparin?
Aster R
J Thromb Haemost . 2005 Oct; 3(10):2166-7. PMID: 16194194
No abstract available.
9.
Prospective evaluation of a new platelet glycoprotein (GP)-specific assay (PakAuto) in the diagnosis of autoimmune thrombocytopenia (AITP)
Davoren A, Bussel J, Curtis B, Moghaddam M, Aster R, McFarland J
Am J Hematol . 2005 Feb; 78(3):193-7. PMID: 15726595
Assays measuring platelet-associated immunoglobulin G (PAIgG), while highly sensitive, lack specificity in diagnosing autoimmune thrombocytopenia (AITP). We prospectively evaluated a new commercially available glycoprotein (GP)-specific assay, the PakAuto (GTI, Brookfield,...
10.
HAMA (human anti-mouse antibodies) do not cause false positive results in PAKPLUS
Tidey L, Chance S, Clarke M, Aster R
Immunohematology . 2004 Sep; 20(3):190-2. PMID: 15373652
No abstract available.